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dAdo is known to be toxic to both proliferating and resting lymphocytes that lack adenosine deaminase (ADA) activity. We now show that human monocytes are also highly sensitive in vitro to nM concentrations of dAdo plus the ADA inhibitor deoxycoformycin, and to the ADA-resistant analog CdA. The dose-and cimedependent toxicity of dAdo or CdA to monocytes is blocked by deoxycytidine, implicating deoxycytidine kinase in the formation of toxic &do or CdA nucleotides. Monocytes exposed to dAdo plus deoxycoformycin, o r to CdA accumulate massive DNA damage detectable within 1 hour. The accumulation of DNA strand breaks in lymphocytes stimulates the lethal consumption of NAD and ATP for poly(ADP-ribose) synthesis. However, monocytes lack the poly(ADP-ribose) polymerase enzyme and therefore show no significant NAD or ATP depletion uncil cell viability declines (12 hr).
Thp DNA damage i n monocytes exposed to CdA is associated wirh a decrease in protein synthesis in vitro, and with inhibition of IL-6 secretion. The selective toxicity of CdA to monocytes was confirmed by in vivo scudies. Thus, the blood monocyte counts, but not the neutrophil counts, fell to 0 in one week in nearly all patients receiving CdA infusion chemotherapy for cutaneous lymphoma. These resulcs show that dAdo and Cdh cause DNA strand break formation and inhibit protein synthesis in human monocytes in vicro, and cause profound monocytopenia in vivo. These compounds may have potential use in the therapy of immune disorders associated with monocyte/macrophage activation. U n l i k e o t h e r n u c l e o s i d e a n t i -m e t a b o l i t e s , ? -chlorodeoxyadenosine is selectively toxic at nanomolnr concentrations to h u m a n lymphocytes and monocytes.
In susceptible cells, the drug causes a dose-and time-dependent accumulation of DNA strand breaks, with resultant activation of poly(ADP-ribose) polymerase. Furthesmore, the actions of 2 -chlorodeoxyadenosine are elltirely indtpendenc of replicative DXA s y n t h e s i s .
F o r t h i s r e a s o n , w e r e a s o n e d c h a t 2 -chlorodeoxyadenosine wouid rzpresent a useful aeent for the troatment of slowly replicating lymphoid malignancies, and for the therapy of chronic autoimmune diseases. In the prasent study. 2-chlorodeoryadenosine was administ<red to 18 parients wich advanced chronic lymp!iozytic leukemia, 4 of whom had c~n~u r r o n t autoimmune he~nolycic anemia. An overall response ruts of 5 6 % was achieved. Only minor and reversible bone marrow supyression occurred during treatment, indicating a high degree of lympllocyte selectivity. Moreover, 3 of the 4 patients with autaimurlr hemolytic anemia h&d complete resolution of hemolysis. Three paiients with hairy cell leukemia also received 2 -cl~lorodeoxyadenosine therapy. Tjro of the patients achieved .clinicdl remission ~E t e r one course of the drug. These results demonstrate that 2-cliloroduosyadanosine is a s a f e and potent anti-lymphocyte and irrmunosuppressive aqent. Furciler trials a f the drug in autoilni.lrine and ly~nptioproliferative diseases are warranted. 2',3'-dideoxyadenosine (ddA) has activity against the human immunodeficiency virus-1 (HIV) , but is rapidly catabolized by human T cells, even when adenosine deaminase is inhibited by deoxycoEormycin. To overcome this problem, we developed a simple method to synthesize the 2-Eluoro-. 2-chloro-, and 2-bromoderivatives of ddA. The isolated 2-halo-ddA derivatives were not deaminated significantly by cultured T lymphoblasts, which converted the dideoxynucleosides to the respective 5'-monophosphate, 5'-diphosphate, and 5'-triphosphate metabolites. At concentrations lower than those producing cytotoxicity in uninfected cells (3-10 pM), the 2-halo-ddA derivatives inhibited the cytopathic effects of HIV toward T lymphoblasts, and retarded viral replication. Experiments wirh a deoxycytidine kinase deficient mutant CEM T cell line showed that this enzyme was necessary for the phosphorylacian and anti-HIV activity of the 2-h a l o -d d~ derivatives. Thus, the 2-halo-ddA congeners, in contrast to ddA itself, are not degraded by T lymphocytes, and represent promising compounds for in vivo chemotherapy of HIV infection.
2-HALO-2',3'-DIDEOXYADENOSINES: METABOLICALLY STABLE DIDEOXYNUCLEOSIDES WITH ACTIVITY AGAINST THE HUMAN
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Chin -Lan & Nao u k i Kamatani. Kusuki Nishioka 20 and :iyonzbu ~i k a n a q y . C l i n i c o f Gout. Taipei Municipal Ho-Pinq Hospital. Taipei. Taiwan. R.O.C. and 1n;titute o f -~h e u k a t o l o~~, jokyo Women's Medical College. Tokyo. Japan Before World War 11, t h e incidence o f gout had been low i n Taiwan and has begun t o increase o n l y a f t e r t h e war. probably r e f l e c t i n g t h e change o f t h e d i e t due t o t h e economical development and improved standards o f l i v i n g i n t h e country. Since our c l i n i c was established i n 1983, we have seen a t o t a l number o f approximately 4.000 p a t i e n t s w i t h gout. The diagnosis o f gout was made according t o t h e c r i t e r i a proposed by t h e American Rheumatism Association. For every gouty p a t i e n t v i s i t i n g our c l i n i c f o r t h e f i r s t time, t h e serum u r a t e concentration and t h e amount o f u r a t e i n the 24-hour u r i n e were examined. The serum u r a t e concentration was checked a t 2 months i n t e r v a l s i n o r d e r t o monitor t h e e f f e c t s o f drugs. I n a d d i t i o n t o these tests, general data i n c l u d i n g hematological findings. serum biochemistry information. u r i n e analysis, r e n a l function, chest X-ray examincation and EKG were obtained every one year f o r each patient. The data from these 4.000 p a t i e n t s have been accumulated and submitted t o the analysis by a computer. Based on such c l i n i c a l and l a b o r a t o r y observations and t h e r e s u l t s obtained by t h e analysis, we discuss about c h a r a c t e r i s t i c features o f gout i n people i n Taiwan. A retrospective study of 49 patients with/or suspected for an immune disease was done to enable a comparision between levels of purine en-zymes in mononuclear cells and some frequently used markers of immune function. A new observation was the finding of correlation between low ecto-5'nucleotidase activity and decreased T lymphocyte function measured as decreased lymphocyte proliferation after mito-and antigenic stimulation in vitro. In this study we did not find correlation between the activity of ecto-5'nucleotidase and the other investigated markers of immune function (lympfocyte count, lymphocyte subpopulations, concentration of immunoglobulines in serum and lymphocyte proliferation after mito-and antigenic stimulation in vitro). The activities of adenosine deaminase and purine nucleoside phosphherylase in mononuclear cells were also measured. In this group of patients no correlation was find between the activities of these enzymes and the investigated markers of immune function. The activity of ecto-S'nucleotidase on monouclear cells isolated from freshly drawn venous blood change during culture. The measured ecto-5'nucleotidase activity on mononuclear cells was much higher than the activity estimated from lymphocytes and monocytes when cultivated separately. The average ecto-5' nucleotidase activity on mononuclear cells after 2 days culture was 86.8 nrnole product developed/h/lo6 cells (u/106 cells) whereas the activity before culture was 22.0 IJ/106 cells. After the same period in culture the activity in lymphocytes and monocytes cultivated separately was 21.2 U/106 cells and 126.2 respectively. These results indicate that the activity of ecto-S'nucleotidase on cultured mononuclear cells is regulated by interactions between lymphocytes and monocytes.
DETECTION OF LOW ECTO-5'NUCLEOTIDASE AC-TIVITY IN MONONUCLEAR CELLS FROM PATIENTS
THE ACTIVITY OF ECTO-S'NUCLEOTIDASE IN CULTURED MONONUCLEAR CELLS IS REGULATED
